Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Valeant Pharmaceuticals International Inc (NYSE:VRX)

8.51
Delayed Data
As of Apr 21
 -0.37 / -4.17%
Today’s Change
8.36
Today|||52-Week Range
38.50
-41.39%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
AssetsCash600.3M322.6M597.3M542.0M
 
 
 
 
 
Short Term Investment Cash-315.8M-277.7M279.9M-55.0M
 
 
 
 
 
Cash & Short Term Investments600.3M322.6M613.3M543.0M
 
 
 
 
 
 
ReceivablesReceivables1.8B2.1B2.7B2.5B
 
 
 
 
 
 
InventoriesInventories883.0M950.6M1.3B1.1B
 
 
 
 
 
 
Current AssetsPrepaid Expenses----20.0M8.0M
 
 
 
Other Current Assets587.8M844.1M930.4M948.0M
 
 
 
 
 
Current Assets3.9B4.2B5.5B5.1B
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross2.1B2.3B2.6B2.5B
 
 
 
 
 
Depreciation-838.8M-977.9M-1.2B-1.2B
 
 
 
 
 
Intangible Assets22.6B20.6B41.6B34.7B
 
 
 
 
 
Other Assets22.8B20.8B41.9B37.0B
 
 
 
 
 
Total Assets28.0B26.4B49.0B43.5B
 
 
 
 
 
 
LiabilitiesAccounts Payable364.6M398.0M433.7M324.0M
 
 
 
 
 
Short Term Debt216.8M7.1M838.5M7.0M
 
 
 
 
 
Accrued Expenses--62.0M364.3M12.0M
 
 
 
 
Other Current Liabilities1.6B2.0B3.6B2.9B
 
 
 
 
 
Other Liabilities2.5B2.7B5.3B3.6B
 
 
 
 
 
 
Total LiabilitiesLong Term Debt17.2B15.3B30.3B29.8B
 
 
 
 
 
Deferred Taxes-2.3B-2.2B-5.7B-5.3B
 
 
 
 
 
Other Liabilities570.9M466.7M1.1B1.0B
 
 
 
 
 
Total Liabilities22.7B20.9B42.9B40.3B
 
 
 
 
 
 
EquityMinority Interest-2.5M-1.3M-3.9M-1.0M
 
 
 
 
 
Preferred Stock0.000.000.000.00--
Common Equity5.1B5.3B5.9B3.2B
 
 
 
 
 
Total Shareholder Equity5.1B5.3B5.9B3.2B
 
 
 
 
 
 
Share InformationCommon Shares Outstanding333.0M334.4M342.9M347.8M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.